Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The lead candidate VK2735 had encouraging results from a phase 2 trial where it achieved its primary endpoint and all secondary endpoints
PCR of wild type allele and targeted allele result in ~1,500bp and ~800bp bands, respectively (left)
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 50 print issues and online access $259.00 per year only $5.18 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Freel, R
US$ 23.29
US$ 28.39
US$ 27.01
US$ 20.31
US$ 26.80
US$ 28.00
US$ 23.47
